Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-28

Clinical Trial Update: Oral Ibuprofen Versus Placebo in Treatment of Patent Ductus Arteriosus (PDA)in Preterm Infants [Phase 2]

View source ↗

Summary

Phase 2 trial comparing oral ibuprofen to placebo for treatment of patent ductus arteriosus in preterm infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Nada Youssef | Conditions: Patent Ductus Arteriosus After Premature Birth, Patent Ductus Arteriosus Conservative Management | Phase 2 | Status: COMPLETED